AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 173 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $300,000 | -5.7% | 31,876 | -23.3% | 0.00% | 0.0% |
| Q2 2020 | $318,000 | +10.8% | 41,547 | -10.5% | 0.00% | 0.0% |
| Q1 2020 | $287,000 | -49.2% | 46,431 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $565,000 | +45.6% | 46,431 | +38.4% | 0.00% | 0.0% |
| Q3 2019 | $388,000 | -24.1% | 33,554 | -34.4% | 0.00% | 0.0% |
| Q2 2019 | $511,000 | +4.3% | 51,161 | +34.4% | 0.00% | 0.0% |
| Q1 2019 | $490,000 | -16.9% | 38,072 | -1.9% | 0.00% | 0.0% |
| Q4 2018 | $590,000 | -24.9% | 38,819 | -1.2% | 0.00% | -50.0% |
| Q3 2018 | $786,000 | +2.6% | 39,294 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $766,000 | -6.2% | 39,294 | -3.1% | 0.00% | 0.0% |
| Q1 2018 | $817,000 | +49.1% | 40,566 | -2.0% | 0.00% | +100.0% |
| Q4 2017 | $548,000 | -51.8% | 41,385 | -32.9% | 0.00% | -50.0% |
| Q3 2017 | $1,137,000 | -33.8% | 61,637 | -34.0% | 0.00% | -50.0% |
| Q2 2017 | $1,718,000 | +414.4% | 93,379 | +531.3% | 0.00% | +300.0% |
| Q1 2017 | $334,000 | -35.1% | 14,792 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $515,000 | +41.9% | 14,792 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $363,000 | +2.5% | 14,792 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $354,000 | +2.3% | 14,792 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $346,000 | -22.6% | 14,792 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $447,000 | -24.0% | 14,792 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $588,000 | -42.5% | 14,792 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $1,022,000 | +42.1% | 14,792 | +12.4% | 0.00% | 0.0% |
| Q1 2015 | $719,000 | +28.2% | 13,157 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $561,000 | -1.9% | 13,157 | -26.7% | 0.00% | 0.0% |
| Q3 2014 | $572,000 | +53.8% | 17,940 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $372,000 | +7.2% | 17,940 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $347,000 | -20.2% | 17,940 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $435,000 | +13.0% | 17,940 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $385,000 | -3.5% | 17,940 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $399,000 | – | 17,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
| Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
| Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
| Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
| FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
| AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
| ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
| Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |